References
1. URL: https://www.worldometers.info
2. Sokolski M., Trenson S., Sokolska J.M., et al. Heart failure in COVID-19: the multicentre, multinational PCHF-COVICAV registry. ESC Heart Fail. 2021; 8: 4955–67. DOI: https://doi.org/10.1002/ehf2.13549
3. Bader F., Manla Y., Atallah B., Starling R.C. Heart failure and COVID-19. Heart failure and COVID-19. Heart Fail Rev. 2021; 26 (1): 1–10. DOI: https://doi.org/10.1007/s10741-020-10008-2
4. Wang D., Hu B., Hu C., et al. Clinical characteristics of 138 patients with 2019 novel coronavirus (2019-nCoV)-infected pneumonia in Wuhan, China. JAMA. 2020; Feb 7. DOI: https://doi.org/10.1001/jama.2020.1585
5. Zhou F., Yu T., Du R., et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395 (10 229): 1054–62. DOI: https://doi.org/10.1016/S0140-6736(20)30566-3
6. Clerkin K.J., Fried J.A., Raikhelkar J., et al. Coronavirus disease 2019 (COVID-19) and cardiovascular disease. Circulation. 2020; 141: 1648–55.
7. Mahmood K., Rashed E.R., Oliveros W., et al. Predisposition or protection? COVID-19 in a patient on LVAD support with HIV/AIDS. JACC Case Rep. 2020; 2: 1337–41.
8. Yamani M.H., Chuang H., Ozduran V., et al. The impact of hypogammaglobulinemia on infection outcome in patients undergoing ventricular assist device implantation. J Heart Lung Transplant. 2006; 25 (7): 820–4. DOI: https://doi.org/10.1016/j.healun.2006.03.009
9. Hodges K., Mubashir M., Insler J., et al. Successful management of COVID-19 and associated coagulopathy in a patient with durable left ventricular assist device. J Card Surg. 2020; 35: 3202–4. DOI: https://doi.org/10.1111/jocs.14937
10. Xanthopoulos A., Triposkiadis F., Starling R.C. Care for patients with ventricular assist devices and suspected COVID-19 infection. Eur J Heart Fail. 2020; 22: 937–40. DOI: https://doi.org/10.1002/ejhf.1907
11. Bikdeli B., Madhavan M.V., Jimenez D., et al. COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up. J Am Coll Cardiol. 2020; 75 (23): 2950–73. DOI: https://doi.org/10.1016/j.jacc.2020.04.031
12. Al-Ani F., Chehade S., Lazo-Langner A. Thrombosis risk associated with COVID-19 infection. A scoping review. Thromb Res. 2020; 192: 152–60. DOI: https://doi.org/10.1016/j.thromres.2020.05.039
13. Klok F., Kruip M., Meer N.V., et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020; 191: 145–7.
14. Interim Clinical Guidance for Management of Patients with Confirmed Coronavirus Disease (COVID-19). Centers for Disease Control and Prevention. Updated Feb 16, 2021.
15. COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. National Institutes of Health. URL: https://www.covid19treatmentguidelines.nih.gov/
16. Belfort D.deS.P., Biselli B., Ávila M.S., et al. COVID-19 complicating perioperative management of LVAD implantation: a case report and systematic review. J Card Surg. 2021; 36: 3405–9. DOI: https://doi.org/10.1111/jocs.15690
17. Wu Z., McGoogan J.M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China. JAMA. 2020; 323 (13): 1239. DOI: https://doi.org/10.1001/jama.2020.2648
18. Goyal P., Reshetnyak E., Khan S., et al. Clinical characteristics and outcomes of adults with a history of heart failure hospitalized for COVID-19. Circ Heart Fail. 2021; 14 (9): e008354. DOI: https://doi.org/10.1161/CIRCHEARTFAILURE.121.008354
19. Bunge J.J.H., Caliskan K., Gommers D., et al. Right ventricular dysfunction during acute respiratory distress syndrome and veno-venous extracorporeal membrane oxygenation. J Thorac Dis. 2018; 10 (suppl 5): S674–82. DOI: https://doi.org/10.21037/jtd.2017.10.75
20. ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2 – care pathways, treatment, and follow-up. The Task Force for the management of COVID-19 of the European Society of Cardiology. Eur Heart J. 2022; 43 (11): 1059–1103. DOI: https://doi.org/10.1093/eurheartj/ehab697